SANTA MONICA, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- JAKKS Pacific, Inc. (NASDAQ: JAKK), a leading global designer, ...
Background Accurate prediction of pathologic response to neoadjuvant chemo-immunotherapy for NSCLC at baseline is important for personalized perioperative treatment selection. However, as a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results